| 000 | 01632 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250511214601.0 | ||
| 264 | 0 | _c19901001 | |
| 008 | 199010s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1990.tb03748.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKarhuvaara, S | |
| 245 | 0 | 0 |
_aPharmacological effects and pharmacokinetics of atipamezole, a novel alpha 2-adrenoceptor antagonist--a randomized, double-blind cross-over study in healthy male volunteers. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cJul 1990 |
||
| 300 |
_a97-106 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xadverse effects |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aC-Peptide _xblood |
| 650 | 0 | 4 |
_aCatecholamines _xurine |
| 650 | 0 | 4 |
_aCyclic AMP _xblood |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrocortisone _xblood |
| 650 | 0 | 4 |
_aImidazoles _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aSalivation _xdrug effects |
| 700 | 1 | _aKallio, A | |
| 700 | 1 | _aScheinin, M | |
| 700 | 1 | _aAnttila, M | |
| 700 | 1 | _aSalonen, J S | |
| 700 | 1 | _aScheinin, H | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 30 _gno. 1 _gp. 97-106 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1990.tb03748.x _zAvailable from publisher's website |
| 999 |
_c1981386 _d1981386 |
||